Evidence map›Paper›PMID 21708946›Full record

ArticleThe Journal of biological chemistry2011

The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity.

Kevin J Paavola, Jason R Stephenson, Stefanie L Ritter, Shawn P Alter, Randy A Hall

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Review
  3. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  4. Review
  5. The far extracellular CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Complex G-protein signaling of the adhesion GPCR, ADGRA3.The Journal of biological chemistry · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Mechanism of tethered agonist-mediated signaling by polycystin-1.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kevin J PaavolaDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia.
Jason R StephensonDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia.
Stefanie L RitterDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia.
Shawn P AlterDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia.
Randy A HallDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: rhall@pharm.emory.edu.
Emory University · US

Funding

Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Activation and regulation of the neural stem cell-expressed receptor GPR56R01NS072394 · NINDS · EMORY UNIVERSITY · PI HALL, RANDY A. · 2011 to 2015
$1.7M
Fundamental Mechanisms of GPR56 Activation and RegulationR21NS063029 · NINDS · EMORY UNIVERSITY · PI HALL, RANDY A. · 2009 to 2010
$270k
NIGMS NIH HHS T32 GM008602NIGMS NIH HHS T32-GM008602NINDS NIH HHS R01 NS072394NINDS NIH HHS R01-NS072394NINDS NIH HHS R21 NS063029NINDS NIH HHS R21-NS063029
6 · The paper itself

Abstract

GPR56 is an adhesion G protein-coupled receptor that plays a key role in cortical development. Mutations to GPR56 in humans cause malformations of the cerebral cortex, but little is known about the normal function of the receptor. We found that the large N terminus (NT) of GPR56 is cleaved from the rest of the receptor during processing but remains non-covalently associated with the seven-transmembrane region of the receptor, as indicated by coimmunoprecipitation of the two GPR56 fragments from both transfected cells and native tissue. We also found that truncation of the GPR56 NT results in constitutive activation of receptor signaling, as revealed by increased GPR56-stimulated signaling upon transfection of HEK-293 cells with truncated GPR56, greatly enhanced binding of β-arrestins by truncated GPR56 relative to the full-length receptor, extensive ubiquitination of truncated GPR56, and cytotoxicity induced by truncated GPR56 that could be rescued by cotransfection of cells with β-arrestin 2. Furthermore, we found that the GPR56 NT is capable of homophilic trans-trans interactions that enhance receptor signaling activity. On the basis of these findings, we suggest a model of receptor activation in which the large N terminus of GPR56 constrains receptor activity but N-terminal interactions (GPR56 NT with an extracellular ligand and/or GPR56 NT homophilic trans-trans associations) can remove this inhibitory influence of the N terminus to activate receptor signaling.

Indexed as

Arrestinsbeta-Arrestin 2beta-ArrestinsCerebral CortexHEK293 CellsHumansMutationProtein Structure, TertiaryReceptors, G-Protein-CoupledSignal TransductionUbiquitinationADGRG1 protein, humanARRB2 protein, humanArrestinsbeta-Arrestin 2beta-ArrestinsReceptors, G-Protein-Coupled

Identifiers

PMID21708946
PMCPMC3190698
OpenAlexW2128870952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.